SOMERVILLE, Mass., May 27, 2025--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird" or "the Company") today reminds all stockholders to promptly tender their shares into the tender ...

A reader called Emer ended up booking not one but two flights for herself and her family to the same destination at the same time through no fault of her own and has struggled for weeks to have ...

Bluebird’s lead CAR-T cancer cell therapy idecabtagene vicleucel (ide-cel) was last year hit with an FDA refuse-to-file letter, which required additional data on chemistry, manufacturing and ...

Update on Sept 13, 2024. American Express confirmed that Bluebird no longer offers new Goal balances or new family sub-accounts. The Bluebird card, offered by American Express, is an FDIC-insured ...

COLUMBUS, Ohio — Two people, including a juvenile, were injured in a shooting in the Short North on Saturday night, police said. Officers with the Columbus Division of Police were called to the ...

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises "substantial doubt" about its ability to continue as a going concern.

017/530 Bridge Street, Toowoomba is a 2 bedroom house. What are the key property features of 017/530 Bridge Street, Toowoomba? To enquire about specific property features for 017/530 Bridge Street ...

Bluebird Mining Ventures Ltd., a pan Asian gold project development company, announces a business update in relation to its gold projects in South Korea. Following the recent positive news in the ...

They welcomed him with open arms, and the run-down brick box at 100 Bridge Street became home to what would become Bluebird Distilling. There were still racks of clothes on hangers when Adkins moved ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”) today reminds all stockholders to promptly tender their shares into the tender offer by Carlyle and ...

Bluebird Bio Inc. defeated allegations it misled investors over the terms regulators would apply for approving its sickle cell treatment, a federal judge ruled. The investor didn’t plausibly allege ...